The epidemiology of hepatitis A virus infections in four Pacific Island nations, 1995-2008

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 103, Issue 9, 2009, Pages 906-910

  Fischer, Gayle E ^a   Thompson, Nicola ^a   Chaves, Sandra S ^a   Bower, William ^a   Goldstein, Susan ^a   Armstrong, Gregory ^a   Williams, Ian ^a   Bialek, Stephanie ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

American Samoa; Federated States of Micronesia; Hepatitis A virus; Pacific Islands; Republic of Palau; Republic of the Marshall Islands

Indexed keywords

HEPATITIS A ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AMERICAN SAMOA; ARTICLE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEDERATED STATES OF MICRONESIA; FEMALE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MARSHALL ISLANDS; MORBIDITY; PACIFIC ISLANDS; PALAU; POPULATION RISK; PREVALENCE; SEROPREVALENCE; SEX DIFFERENCE; VULNERABLE POPULATION;

AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS; HUMANS; MALE; PACIFIC ISLANDS;

HEPATITIS A VIRUS;

EID: 68249118992     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2009.05.001     Document Type: Article

References (17)

1. Wong D.C., Purcell R.H., and Rosen L. Prevalence of antibody to hepatitis A and hepatitis B viruses in selected populations of the South Pacific. Am J Epidemiol 110 (1979) 227-236
2. Withers B.G., Kelley P.W., Pang L.W., Kustermann J.A., MacArthy P.O., Russell B.J., et al. Vaccine-preventable disease susceptibility in a young adult Micronesian population. Southeast Asian J Trop Med Public Health 25 (1994) 569-574
3. Jacobsen K.H., and Koopman J.S. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 132 (2004) 1005-1022
4. Hadler S.C., Webster H.M., Erben J.J., Swanson J.E., and Maynard J.E. Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med 302 (1980) 1222-1227
5. Lednar W.M., Lemon S.M., Kirkpatrick J.W., Redfield R.R., Fields M.L., and Kelley P.W. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 122 (1985) 226-233
6. Williams I.T., Goldstein S.T., Tufa J., Tauillii S., Margolis H.S., and Mahoney F.J. Long-term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J 22 (2003) 157-163
7. Mahoney F.J., Woodruff B.J., Auerback S., Polloi A., McCready J., Durand M., et al. Progress on the elimination of hepatitis B virus transmission in Micronesia and American Samoa. Pacific Health Dialog 3 (1997) 140-146
8. Melnick J.L. History and epidemiology of hepatitis A virus. J Infect Dis 171 Suppl 1 (1995) S2-8
9. UN. Federated States of Micronesia [updated 5 January 2000]. http://ww2.unhabitat.org/habrdd/conditions/micronesia/micronesiafs.htm [accessed 1 May 2009].
10. UN. Palau [updated 5 January 2000]. http://ww2.unhabitat.org/habrdd/conditions/micronesia/palau.htm [accessed 1 May 2009].
11. UN. American Samoa [updated 4 January 2000]. http://ww2.unhabitat.org/habrdd/conditions/polynesia/amsamoa.htm [accessed 1 May 2009].
12. UN. Marshall Islands [updated 5 January 2000]. http://ww2.unhabitat.org/habrdd/conditions/micronesia/marshall.htm [accessed 1 May 2009].
13. CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep 1999;48:1-54.
14. Berge J.J., Drennan D.P., Jacobs R.J., Jakins A., Meyerhoff A.S., Stubblefield W., et al. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology 31 (2000) 469-473
15. Williams IBB, Kaluba J, Shapiro C. Association between chronic liver disease and death from hepatitis A, United States 1989-1992 (abstract no. A39). In: IX Triennial International Symposium on Viral Hepatitis and Liver Disease, Rome, 1996
16. Valenzuela M.T., Jacobs R.J., Arteaga O., Navarrete M.S., Meyerhoff A.S., and Innis B.L. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile. Vaccine 23 (2005) 4110-4119
17. Lopez E., Debbag R., Coudeville L., Baron-Papillon F., and Armoni J. The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health-economic analysis. J Gastroenterol 42 (2007) 152-160